The ACP is recognised by the Royal College of Physicians and the Department of Health as the specialty association for medical oncologists. The executive committee is made up of democratically elected clinicians representing the views and concerns of the membership. Membership of the ACP gives medical oncologists an independent voice in the affairs of the Royal College of Physicians, the Joint Collegiate Council for Oncology (JCCO) and the Specialty Advisory Committee (SAC), who supervise training and accreditation.
Through this, we:
If you are working as a medical oncologist, or a trainee, in the UK then we would urge you to join. Details here.
To assist clinicians facing the current and significant challenges providing systemic therapies to cancer patients, the ACP is collating links to key relevant documents for medical oncologists. New and updated documents will be added as they are released but you are advised to familiarise yourself with these resources.
Posted on
The UK Chemotherapy Board has produced a guidance document which addresses key questions raised by health care professionals relating to the administration of the Pfizer/BioNTech and Oxford/AZ COVID-19 vaccines in patients on SACT. It will be updated as new information and vaccines, eg Moderna, become available. A link to the document is here.Posted on
The ACP acknowledges the enormous impact of the COVID-19 pandemic on society, the entire UK health service, and especially on the provision of cancer care. With many lessons already learned from the first peak, we are now in a better position to use this knowledge to help inform and adapt our clinical practice and overcome the challenges of continuing to provide and maintain safe and effecti...Posted on
The ACP is delighted that the most recent title in the award-winning Problem Solving series has now been published by EBN Health. Details here.